名称 | 銘柄コード | 市場 | 種別 |
---|---|---|---|
NanoViricides Inc | NNVC | AMEX | 普通株式 |
始値 | 安値 | 高値 | 終値 | 前日終値 |
---|---|---|---|---|
1.23 | 1.14 | 1.23 | 1.13 | 1.20 |
最新ニュース
日付 | 時間 | ソース | タイトル |
---|---|---|---|
2024/2/17 | 06:53 | EDGAR2 | Form 8-K - Current report |
2024/2/15 | 06:55 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2024/1/20 | 06:44 | EDGAR2 | Form 8-K - Current report |
2023/12/05 | 06:08 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
2023/10/14 | 05:30 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
2023/9/29 | 05:44 | EDGAR2 | Form NT 10-K - Notification of inability to timely file Form.. |
2023/9/02 | 05:46 | EDGAR2 | Form 8-K - Current report |
2023/7/07 | 00:16 | IHNW | Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is.. |
2023/5/04 | 19:45 | GLOBE | NanoViricides, Inc. to Present at The Inaugural Ef Hutton.. |